Atlas Trials

Study to Evaluate the Treatment Benefits of Probiotic Clostridium Butyricum CBM588® for IBS-D

Clinical trial NCT06676514 · COMPLETED

Trial details

NCT number
NCT06676514
Sponsor
Liaquat University of Medical & Health Sciences
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
IBS-D (Diarrhea-predominant)
Start date
2024-11-10
Primary completion
2025-02-24
Enrollment
405

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.